Vivimed Labs Ltd. - Research Center
532660 VIVIMEDLAB Group (Z) BSE data
Results
Statement
More
| Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
| 16.58 |
16.58 |
16.58 |
16.58 |
16.51 |
Share application money
Preference share capital
Reserves & surplus
| 78.73 |
402.69 |
469.89 |
499.31 |
518.12 |
Secured loans
| 376.64 |
356.94 |
250.80 |
255.34 |
248.52 |
Unsecured loans
Total
| 471.96 |
776.22 |
737.27 |
771.23 |
838.46 |
Gross block
| 553.89 |
535.17 |
507.67 |
434.38 |
451.32 |
Less : revaluation reserve
| 38.00 |
38.00 |
38.00 |
38.00 |
38.00 |
Less : accumulated depreciation
| 211.03 |
106.37 |
91.17 |
77.96 |
70.62 |
Net block
| 304.86 |
390.81 |
378.50 |
318.42 |
342.70 |
Capital work-in-progress
| 20.67 |
40.03 |
58.45 |
69.77 |
64.18 |
Investments
| 161.14 |
161.14 |
161.14 |
87.50 |
87.53 |
Current assets, loans & advances
| 267.59 |
441.82 |
458.75 |
553.64 |
622.14 |
Less : current liabilities & provisions
| 282.29 |
257.57 |
319.57 |
258.09 |
278.10 |
Total net current assets
| -14.70 |
184.24 |
139.18 |
295.55 |
344.04 |
Miscellaneous expenses not written
Total
| 471.96 |
776.22 |
737.27 |
771.23 |
838.46 |
Book value of unquoted investments
| 161.14 |
161.14 |
161.14 |
87.50 |
87.53 |
Market value of quoted investments
Contingent liabilities
| 123.42 |
215.57 |
220.66 |
11.54 |
55.52 |
Number of equity sharesoutstanding (Lacs)
| 829.14 |
829.14 |
829.14 |
829.14 |
825.24 |